Department of Physiology, University of Pennsylvania School of Medicine, B39 Anatomy-Chemistry Bldg., 414 Guardian Dr., Philadelphia, PA 19104, USA.
Pflugers Arch. 2010 Jul;460(2):481-94. doi: 10.1007/s00424-010-0826-0. Epub 2010 Apr 10.
The modulation of cytoplasmic Ca2+ concentration by release from internal stores through the inositol trisphosphate receptor (InsP3R) Ca2+ release channel is a ubiquitous signaling system involved in the regulation of numerous processes. Because of its ubiquitous expression and roles in regulating diverse cell physiological processes, it is not surprising that the InsP3R has been implicated in a number of disease states. However, relatively few mutations in InsP3R genes have been identified to date. Here, I will discuss mutations in the type 1 InsP3R that have been discovered by analyses of human patients and mice with neurological disorders. In addition, I will highlight diseases caused by mutations in other genes, including Huntington's and Alzheimer's diseases and some spinocerebellar ataxias, where the mutant proteins have been found to exert strong influences on InsP3R function that may link InsP3R to disease pathogenesis.
通过肌醇三磷酸受体(InsP3R)Ca2+ 释放通道从内部储存中释放来调节细胞质 Ca2+ 浓度是一种普遍存在的信号系统,参与调节许多过程。由于其广泛表达和在调节多种细胞生理过程中的作用,InsP3R 与许多疾病状态有关也就不足为奇了。然而,迄今为止,仅发现了 InsP3R 基因的相对较少的突变。在这里,我将讨论通过对具有神经障碍的人类患者和小鼠的分析发现的 1 型 InsP3R 突变。此外,我将重点介绍由其他基因突变引起的疾病,包括亨廷顿病和阿尔茨海默病以及一些脊髓小脑共济失调,其中已发现突变蛋白对 InsP3R 功能具有很强的影响,这可能将 InsP3R 与疾病发病机制联系起来。